Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Cassingena
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
Cancer Research
Cancer Research
Oncology
Related publications
Acquired Resistance to BRAF Inhibition in BRAFV600E Mutant Gliomas
Oncotarget
Oncology
Dissecting Mechanisms of Resistance to Targeted Drug Combination Therapy in Human Colorectal Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer
Nature
Multidisciplinary
mTORC1/autophagy-regulated MerTK in Mutant BRAFV600 Melanoma With Acquired Resistance to BRAF Inhibition
Oncotarget
Oncology
Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
Author Correction: PAK Signalling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-mutant Melanomas
Nature
Multidisciplinary
Acquired Resistance to BRAF Inhibition Can Confer Cross-Resistance to Combined BRAF/MEK Inhibition
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Molecular Mechanisms of Acquired Resistance to Third-Generation EGFR-TKIs in EGFR T790m-Mutant Lung Cancer
Annals of Oncology
Medicine
Oncology
Hematology
Targeted Therapy for Patients With BRAF-Mutant Lung Cancer Results From the European EURAF Cohort
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary